Welcome to the e-CCO Library Archive!
Are gene hunting days over?
Presentation - ECCO'12 Barcelona Congress
Miles Parkes
Are pre-clinical data useful?
Presentation - ECCO 2015 Barcelona Congress - 4th ClinCom Workshop Session 1: What’s next in IBD drug development?
Van den Brink Gijs
Are pre-clinical data useful?
Presentation - ECCO 2015 Barcelona Congress - 4th ClinCom Workshop Session 1: What’s next in IBD drug development?
Van den Brink Gijs
Are stem cells ready for clinical practice?
Presentation - ECCO'12 Barcelona Congress
Gijs Van der Brink
Are we ready to abandon placebo in our RCTs? Pros and cons
Presentation - ECCO 2015 Barcelona Congress - Advanced ECCO: EduCational COurse for Industry
Danese Silvio
Are we ready to manage the microbiome?
Presentation - ECCO'12 Barcelona Congress
Arlette Darfeuille-Michaud
Assessing endoscopic and disease activity in practice
Presentation - ECCO'12 Barcelona Congress
Gert van Assche
Assessment and reassessment of paediatric IBD
Presentation - ECCO 2015 Barcelona Congress - PIBD Update 2015
Richard Russell
Assessment of disease activity
Presentation - ECCO 2015 Barcelona Congress - 6th N-ECCO School Session 1: Diagnosis and assessment (IBD, CD, UC, IBDQ, Montreal classification)
O'Connor Marian
Assessment of disease activity
Presentation - ECCO 2015 Barcelona Congress - ECCO-ESGAR MRI Workshop 3: Session 2: Assessment of disease activity (Keywords: anti-TNF, ECCO, IBD, MRI, ultrasonography)
Taylor Stuart
Awards and Closing remarks
Presentation - ECCO 2013 Vienna Congress – Awards and Closing remarks
Simon Travis
Basic principles of histological IBD diagnosis
Presentation - ECCO 2016 Amsterdam Congress - 1st H-ECCO IBD Masterclass: Session 1: Basic aspects of IBD Pathology (Keywords: IBD, CD, UC, histopathology)
Roger Feakins
Best abstract 3: Development of a web-based application to improve quality of life in IBD patients
Presentation - ECCO 2015 Barcelona Congress - 9th N-ECCO Network Meeting: Session 3: Are we optimising our options? Investigation and interpretation (Keywords: IBD, IBDQ, nurse, faecal incontinence, app, toilet)
Francisca Murciano Gonzalo
Best abstract: A randomised, double-blind, placebo- controlled induction trial of an oral S1P receptor modulator (RPC1063) in moderate to severe Ulcerative Colitis: Results of the TOUCHSTONE study
Presentation - ECCO 2015 Barcelona Congress - Scientific session 10: New therapies and strategies
William Sandborn
Best abstract: Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn’s Disease: Results of the OPERA study
Presentation - ECCO 2015 Barcelona Congress - Scientific session 10: New therapies and strategies
Geert D'Haens
Best abstract: Long-term outcomes in a cohort of patients with Acute Severe Ulcerative Colitis refractory to intravenous steroids treated with cyclosporine or infliximab
Presentation - ECCO 2015 Barcelona Congress - Scientific session 7: ECCO Fellowships and Grants (Keywords: AZA, colectomy, cyclosporine, UC, infliximab)
David Laharie
Best abstract: Methotrexate for corticosteroid-dependent Ulcerative Colitis: Results of a placebo randomised controlled trial
Presentation - ECCO 2015 Barcelona Congress - Scientific session 10: New therapies and strategies
Franck Carbonnel
Best abstract: Patients with Inflammatory Bowel Disease and a history of cancer: The risk of cancer following exposure to immunosuppression
Presentation - ECCO 2015 Barcelona Congress - Scientific session 9: What’s new on the guideline front? (Keywords: mercaptopurine, adalimumab, adenocarcinoma, anti-TNF, AZA, cancer, cancer in ibd, certolizumab, IBD, CD, UC, immonusuppressive agents, infliximab, lymphoma, methotrexate)
Jordan Axelrad
Best abstract: 16S rRNA gene pyrosequencing indicate that siblings of Crohn's Disease patients exhibit a biologically relevant dysbiosis in the mucosal microbiota communities
Presentation - ECCO 2014 Copenhagen Congress - Scientific session 10: Colitis under the microscope: Best abstract: 16S rRNA gene pyrosequencing indicate that siblings of Crohn's Disease patients exhibit a biologically relevant dysbiosis in the mucosal microbiota communities (Keywords: environmental factors, environmental risk factors, IBD, CD, siblings, dysbiosis, microbiota)
Charlotte Hedin
Best abstract: 52-week clinical efficacy with Adalimumab in patients with Moderatly to Severely Active Ulcerative Colitis who failed corticosteroids and/or immunosuppressants
Presentation - ECCO'11 Dublin Congress
Walter Reinisch